Immune response of human propagated gammadelta-T-cells to neuroblastoma recommend the Vdelta1+ subset for gammadelta-T-cell-based immunotherapy - Schilbach, K; Frommer, K; Meier, S; Handgretinger, R; Eyrich, M (J Immunother, 2008)